Literature DB >> 15805318

Ultrasound with topical anesthetic rapidly decreases pain of intravenous cannulation.

Bruce M Becker1, Sara Helfrich, Elizabeth Baker, Kirsten Lovgren, P Allison Minugh, Jason T Machan.   

Abstract

OBJECTIVES: Physicians and nurses in the emergency department rarely use topical anesthesia when starting intravenous (IV) lines because of time constraints and lack of data on patients' perception of the pain associated with this procedure. Ultrasound pretreatment of skin increases permeation rates of hydrophobic topical medications, including topical lidocaine. The objective of this study was to demonstrate that ultrasound treatment followed by brief application of topical anesthetic decreases the patients' perception of the pain of IV cannulation.
METHODS: This was a randomized, controlled, prospective trial performed in a university hospital emergency department. Eighty-seven consecutive English-speaking, subcritically injured or ill adult patients able to give consent who were receiving an IV line as part of their care were enrolled. The intervention was a brief ultrasound treatment using the SonoPrep (Sontra Medical Corp., Franklin, MA) therapeutic ultrasound device (frequency, 53-56 kHz) followed by 5 minutes of 4% liposomal lidocaine cream and standard-care IV cannulation, or standard care alone. Participants rated their pain on a visual analog scale. Researchers assessed the site after IV insertion and 20-36 hours later. The primary outcome was participants' subjective pain score, and the secondary outcome was site skin irritation.
RESULTS: The ultrasound group reported significantly less pain (p<0.001), with 80% of treated participants reporting pain scores </=3 versus only 37% of controls (p <0.001).
CONCLUSIONS: The SonoPrep ultrasound device applied to skin for 15 seconds followed by 5 minutes of 4% liposomal lidocaine cream significantly reduced patients' perception of the pain of an IV start when compared with standard care. There were no adverse side effects noted in any participant during the 36 hours of the follow-up period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805318     DOI: 10.1197/j.aem.2004.11.019

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  16 in total

1.  Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: Comparative in vitro studies with full-thickness and split-thickness pig and human skin.

Authors:  Jennifer E Seto; Baris E Polat; Renata F V Lopez; Daniel Blankschtein; Robert Langer
Journal:  J Control Release       Date:  2010-03-25       Impact factor: 9.776

2.  Sampling of disease biomarkers from skin for theranostic applications.

Authors:  Makoto Ogura; Sumit Paliwal; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

3.  Pilot studies of transdermal continuous glucose measurement in outpatient diabetic patients and in patients during and after cardiac surgery.

Authors:  Han Chuang; My-Quyen Trieu; James Hurley; Elizabeth J Taylor; Michael R England; Stanley A Nasraway
Journal:  J Diabetes Sci Technol       Date:  2008-07

Review 4.  Single compartment drug delivery.

Authors:  Michael J Cima; Heejin Lee; Karen Daniel; Laura M Tanenbaum; Aikaterini Mantzavinou; Kevin C Spencer; Qunya Ong; Jay C Sy; John Santini; Carl M Schoellhammer; Daniel Blankschtein; Robert S Langer
Journal:  J Control Release       Date:  2014-05-04       Impact factor: 9.776

Review 5.  Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends.

Authors:  Baris E Polat; Douglas Hart; Robert Langer; Daniel Blankschtein
Journal:  J Control Release       Date:  2011-01-14       Impact factor: 9.776

Review 6.  Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.

Authors:  Baris E Polat; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2010-12       Impact factor: 6.648

7.  Application of the aqueous porous pathway model to quantify the effect of sodium lauryl sulfate on ultrasound-induced skin structural perturbation.

Authors:  Baris E Polat; Jennifer E Seto; Daniel Blankschtein; Robert Langer
Journal:  J Pharm Sci       Date:  2010-10-20       Impact factor: 3.534

Review 8.  Transdermal drug delivery.

Authors:  Mark R Prausnitz; Robert Langer
Journal:  Nat Biotechnol       Date:  2008-11       Impact factor: 54.908

9.  Rapid sampling of molecules via skin for diagnostic and forensic applications.

Authors:  Sumit Paliwal; Makoto Ogura; Samir Mitragotri
Journal:  Pharm Res       Date:  2010-03-18       Impact factor: 4.200

Review 10.  An overview of clinical and commercial impact of drug delivery systems.

Authors:  Aaron C Anselmo; Samir Mitragotri
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.